The efficacy and safety of a taxane-based chemotherapy regimen combined with a PD-1 inhibitor in HNSCC: a multicenter real-world study
Abstract Objective This study aims to elucidate the therapeutic efficacy and safety of a taxane-based chemotherapy in combination with immune checkpoint inhibitors regimen in patients diagnosed with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). Methods We retrospectively col...
Saved in:
Main Authors: | Min Ouyang, Hanquan Sun, Xiaoyu Liu, Haijun Wu, Feilong Deng, Erdong Shen, Guozheng Peng, Hanbing Wu, Yinshan Zhao, Hui Xiong, Bin Liu, Shasha He, Ying Hu, Ping Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12957-024-03644-7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Disulfidptosis-related gene signatures as prognostic biomarkers and predictors of immunotherapy response in HNSCC
by: Haotian Qin, et al.
Published: (2025-01-01) -
Expression and prognostic significance of the m6A RNA methylation regulator HNRNPC in HNSCC
by: Yulin Zhang, et al.
Published: (2025-02-01) -
Multiple machine learning-based integrations of multi-omics data to identify molecular subtypes and construct a prognostic model for HNSCC
by: Xiaoqin Luo, et al.
Published: (2025-02-01) -
Depth-dependent PD-L1 sampling of head and neck squamous cell carcinoma (HNSCC) – implications for PD-1/PD-L1 checkpoint inhibitor immunotherapy
by: Madhusudan Roy, et al.
Published: (2024-03-01) -
Case Report: Metastatic squamous cell carcinoma in the left atrium
by: Shuai Luo, et al.
Published: (2025-01-01)